Return to Home Incidence > Table

Incidence Rates Table

Data Options

Incidence Rate Report by State

Liver & Bile Duct (All Stages^), 2016-2020

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank
State
 sort alphabetically by name ascending
Age-Adjusted Incidence Rate
cases per 100,000
(95% Confidence Interval)
 sort by rate descending
CI*Rank⋔
(95% Confidence Interval)
 sort by CI rank ascending
Average Annual Count
 sort by count descending
Recent Trend
Recent 5-Year Trend in Incidence Rates
(95% Confidence Interval)
 sort by trend descending
US (SEER+NPCR) 1 8.6 (8.5, 8.6) N/A 34,900 stable stable trend 0.0 (-0.4, 0.5)
Wyoming 6 5.4 (4.7, 6.2) 49 (43, 49) 43 stable stable trend -8.9 (-19.9, 4.0)
Nebraska 6 5.9 (5.5, 6.4) 48 (43, 49) 140 stable stable trend 0.6 (-4.6, 2.3)
Vermont 6 6.0 (5.3, 6.7) 47 (39, 49) 56 stable stable trend -1.8 (-5.9, 0.7)
Utah 7 6.4 (6.0, 6.8) 46 (40, 49) 186 stable stable trend 1.3 (-3.0, 3.7)
North Dakota 6 6.4 (5.7, 7.2) 45 (32, 49) 58 rising rising trend 11.0 (5.5, 21.3)
Maine 6 6.5 (6.0, 7.0) 44 (36, 49) 136 rising rising trend 8.0 (1.3, 13.0)
Montana 6 6.7 (6.1, 7.4) 43 (31, 48) 104 rising rising trend 4.6 (3.1, 6.5)
New Hampshire 6 6.7 (6.2, 7.3) 42 (33, 48) 132 rising rising trend 3.4 (1.8, 5.5)
South Dakota 6 6.9 (6.2, 7.7) 41 (25, 48) 77 rising rising trend 6.0 (4.4, 8.0)
Michigan 6 7.0 (6.8, 7.2) 40 (35, 44) 968 stable stable trend -0.5 (-2.8, 1.7)
Iowa 7 7.1 (6.8, 7.5) 39 (31, 44) 297 rising rising trend 4.0 (3.5, 4.5)
Virginia 6 7.2 (7.0, 7.4) 38 (32, 43) 777 stable stable trend 2.6 (-4.8, 6.4)
Kansas 6 7.2 (6.8, 7.6) 37 (30, 44) 267 stable stable trend 0.0 (-3.3, 4.4)
Colorado 6 7.2 (7.0, 7.6) 36 (31, 43) 489 stable stable trend 0.7 (-4.0, 2.1)
Wisconsin 6 7.3 (7.1, 7.6) 35 (30, 42) 576 stable stable trend -1.3 (-4.0, 1.5)
Connecticut 7 7.5 (7.1, 7.8) 34 (27, 41) 369 falling falling trend -2.6 (-6.0, -0.1)
Ohio 6 7.6 (7.4, 7.8) 33 (29, 37) 1,201 rising rising trend 2.7 (2.1, 3.3)
Idaho 7 7.6 (7.1, 8.2) 32 (19, 43) 166 stable stable trend -1.6 (-5.5, 2.5)
Arizona 6 7.7 (7.4, 8.0) 31 (25, 36) 728 stable stable trend -0.6 (-3.5, 1.3)
Minnesota 6 7.9 (7.6, 8.2) 30 (20, 35) 555 rising rising trend 5.7 (4.8, 7.1)
West Virginia 6 7.9 (7.5, 8.4) 29 (13, 37) 214 rising rising trend 4.5 (3.5, 5.8)
Florida 6 7.9 (7.8, 8.1) 28 (23, 32) 2,536 rising rising trend 1.7 (0.8, 2.2)
South Carolina 6 8.0 (7.7, 8.3) 27 (19, 34) 563 stable stable trend -0.4 (-5.1, 3.3)
New Jersey 7 8.0 (7.8, 8.3) 26 (19, 32) 935 stable stable trend 0.5 (-1.5, 2.3)
Illinois 7 8.1 (7.9, 8.3) 25 (19, 31) 1,297 rising rising trend 2.9 (2.5, 3.3)
Missouri 6 8.1 (7.8, 8.4) 24 (17, 32) 667 stable stable trend 1.4 (-1.1, 2.6)
Delaware 6 8.2 (7.5, 8.9) 23 (7, 37) 115 stable stable trend -3.9 (-13.8, 1.5)
Alabama 6 8.3 (8.0, 8.6) 22 (11, 30) 544 rising rising trend 4.1 (3.4, 5.0)
Kentucky 7 8.4 (8.0, 8.7) 21 (10, 30) 490 stable stable trend 0.0 (-3.5, 2.5)
Georgia 7 8.4 (8.2, 8.6) 20 (12, 26) 1,039 stable stable trend 0.8 (-2.6, 3.2)
Arkansas 6 8.5 (8.1, 8.9) 19 (8, 29) 336 rising rising trend 5.0 (1.3, 7.1)
Pennsylvania 6 8.5 (8.3, 8.7) 18 (11, 24) 1,541 stable stable trend -1.0 (-2.9, 1.1)
Tennessee 6 8.6 (8.3, 8.8) 17 (9, 24) 763 stable stable trend -0.5 (-3.2, 1.6)
Mississippi 6 8.6 (8.2, 9.1) 16 (7, 27) 333 stable stable trend -0.7 (-4.6, 3.9)
New York 7 8.7 (8.5, 8.8) 15 (9, 21) 2,204 falling falling trend -2.2 (-3.2, -1.3)
Massachusetts 7 8.7 (8.4, 9.0) 14 (7, 23) 783 stable stable trend 1.3 (-0.4, 2.2)
North Carolina 6 8.7 (8.5, 8.9) 13 (8, 22) 1,177 stable stable trend 1.0 (-0.6, 2.2)
Maryland 6 8.7 (8.5, 9.1) 12 (7, 22) 677 stable stable trend 0.5 (-2.3, 2.6)
Oklahoma 6 8.8 (8.4, 9.2) 11 (7, 23) 439 rising rising trend 3.8 (2.9, 4.8)
Washington 5 8.9 (8.7, 9.2) 10 (7, 18) 846 stable stable trend -0.2 (-1.7, 1.0)
Rhode Island 6 9.1 (8.4, 9.8) 9 (4, 26) 130 rising rising trend 2.2 (1.1, 3.6)
Oregon 6 9.1 (8.7, 9.4) 8 (6, 18) 525 stable stable trend -1.2 (-4.6, 1.2)
Alaska 6 9.4 (8.4, 10.5) 7 (2, 29) 75 rising rising trend 2.1 (0.6, 4.1)
California 7 9.6 (9.4, 9.7) 6 (4, 8) 4,435 stable stable trend -1.1 (-2.7, 0.2)
Hawaii 7 9.8 (9.2, 10.5) 5 (2, 11) 190 falling falling trend -7.3 (-11.7, -2.6)
New Mexico 7 10.0 (9.5, 10.6) 4 (2, 8) 279 stable stable trend -2.2 (-6.4, 2.9)
Louisiana 7 10.5 (10.1, 10.9) 3 (2, 5) 634 rising rising trend 3.7 (2.9, 4.7)
District of Columbia 6 11.4 (10.3, 12.6) 2 (1, 5) 83 stable stable trend -2.5 (-6.7, 0.1)
Texas 7 12.1 (11.9, 12.2) 1 (1, 2) 3,726 stable stable trend 0.4 (-1.4, 1.6)
Indiana 6
data not available
N/A
data not available
data not available
data not available
Nevada 6
data not available
N/A
data not available
data not available
data not available
Puerto Rico 6 8.2 (7.8, 8.6) N/A 365 stable stable trend -2.7 (-9.1, 4.0)
Notes:
Created by statecancerprofiles.cancer.gov on 03/19/2024 3:46 am.

State Cancer Registries may provide more current or more local data.
Trend
Rising when 95% confidence interval of average annual percent change is above 0.
Stable when 95% confidence interval of average annual percent change includes 0.
Falling when 95% confidence interval of average annual percent change is below 0.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.
‡ Incidence data come from different sources. Due to different years of data availability, most of the trends are AAPCs based on APCs but some are APCs calculated in SEER*Stat. Please refer to the source for each area for additional information.

Rates and trends are computed using different standards for malignancy. For more information see malignant.html.

^ All Stages refers to any stage in the Surveillance, Epidemiology, and End Results (SEER) summary stage.
⋔ Results presented with the CI*Rank statistics help show the usefulness of ranks. For example, ranks for relatively rare diseases or less populated areas may be essentially meaningless because of their large variability, but ranks for more common diseases in densely populated regions can be very useful. More information about methodology can be found on the CI*Rank website.

Data not available for this combination of data selections.

1 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
5 Source: National Program of Cancer Registries and Surveillance, Epidemiology, and End Results SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention and National Cancer Institute. Based on the 2022 submission.
6 Source: National Program of Cancer Registries SEER*Stat Database - United States Department of Health and Human Services, Centers for Disease Control and Prevention (based on the 2022 submission).
7 Source: SEER November 2022 submission.
8 Source: Incidence data provided by the SEER Program. AAPCs are calculated by the Joinpoint Regression Program and are based on APCs. Data are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84,85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Population counts for denominators are based on Census populations as modifed by NCI. The US Population Data File is used with SEER November 2022 data.
Data not available for this combination of geography, cancer site, age, and race/ethnicity.

Data for the United States does not include data from Nevada.
Data for the United States does not include Puerto Rico.
CI*Rank data for Puerto Rico is not available.

Return to Top